APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cancer Rapid Diagnostic Kit

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Cancer Rapid Diagnostic Kit Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

4 July 2026199 pages

Choose your research edition.

Industry ResearchCancer Rapid Diagnostic Kit Industry Research Report 2026142 pages · $2,950 USDIndustry Growth & TrendsGlobal Cancer Rapid Diagnostic Kit Industry Growth and Trends Forecast to 2032129 pages · $3,450 USDMarket StructureGlobal Cancer Rapid Diagnostic Kit Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cancer Rapid Diagnostic Kit Market Outlook and Growth Opportunities 2026212 pages · $4,250 USDMarket Analysis & ForecastGlobal Cancer Rapid Diagnostic Kit Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global Cancer Rapid Diagnostic Kit market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Cancer Rapid Diagnostic Kit is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cancer Rapid Diagnostic Kit is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cancer Rapid Diagnostic Kit is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Cancer Rapid Diagnostic Kit is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cancer Rapid Diagnostic Kit include Yaneng Bioscience (Shenzhen) Co., Ltd., Xian Tianlong Science and Technology Co.,Ltd, XIAMEN SPACEGEN CO.,LTD, Xiamen Biotime Biotechnology Co., Ltd., ViennaLab Diagnostics, ShenZhen Zijian Biotechnology Co.,Ltd., Shenzhen Kangshengbao Biotechnology, Shanghai Outdo Biotech Co., Ltd. and Seegene, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Cancer Rapid Diagnostic Kit market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cancer Rapid Diagnostic Kit and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cancer Rapid Diagnostic Kit sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cancer Rapid Diagnostic Kit market size, projected growth trends, production technologies, key applications, and end-use industries.

Cancer Rapid Diagnostic Kit Segment by Company

Yaneng Bioscience (Shenzhen) Co., Ltd.

Xian Tianlong Science and Technology Co.,Ltd

XIAMEN SPACEGEN CO.,LTD

Xiamen Biotime Biotechnology Co., Ltd.

ViennaLab Diagnostics

ShenZhen Zijian Biotechnology Co.,Ltd.

Shenzhen Kangshengbao Biotechnology

Shanghai Outdo Biotech Co., Ltd.

Seegene

Sansure Biotech

Panagene Inc.

OptiBio Co., Ltd.

LCM Genect

Kolplast Group

Jiangsu Mole Bioscience CO., LTD.

Jiangsu MicroDiag Biomedicine Technology Co., Ltd.

Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.

IDL Biotech

GenomeMe Labs Inc

Genetic Biotek

Gencurix

Fujirebio

Diagenode

Boditech Med Inc.

Bioscience (Tianjin) Diagnostic Technology Co.,Ltd

Beijing ACCB Biotech Ltd.

Asuragen

Cancer Rapid Diagnostic Kit Segment by Type

Test For Tumor Markers

Test Gene

Test Protein

Others

Cancer Rapid Diagnostic Kit Segment by Application

Hospital

Clinic

Cancer Rapid Diagnostic Kit Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cancer Rapid Diagnostic Kit market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cancer Rapid Diagnostic Kit and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cancer Rapid Diagnostic Kit.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cancer Rapid Diagnostic Kit market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cancer Rapid Diagnostic Kit manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Cancer Rapid Diagnostic Kit in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Cancer Rapid Diagnostic Kit in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Cancer Rapid Diagnostic Kit Industry Trends Table 2. Cancer Rapid Diagnostic Kit Industry Drivers Table 3. Cancer Rapid Diagnostic Kit Industry Opportunities and Challenges Table 4. Cancer Rapid Diagnostic Kit Industry Restraints Table 5. Global Cancer Rapid Diagnostic Kit Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Cancer Rapid Diagnostic Kit Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Cancer Rapid Diagnostic Kit Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Cancer Rapid Diagnostic Kit Sales Market Share by Manufacturers Table 9. Global Cancer Rapid Diagnostic Kit Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Cancer Rapid Diagnostic Kit Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Cancer Rapid Diagnostic Kit Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Cancer Rapid Diagnostic Kit Manufacturers, Product Type & Application Table 13. Global Cancer Rapid Diagnostic Kit Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Cancer Rapid Diagnostic Kit by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Test For Tumor Markers Table 17. Major Manufacturers of Test Gene Table 18. Major Manufacturers of Test Protein Table 19. Major Manufacturers of Others Table 20. Global Cancer Rapid Diagnostic Kit Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Cancer Rapid Diagnostic Kit Sales by Type (2021-2026) & (k units) Table 22. Global Cancer Rapid Diagnostic Kit Sales by Type (2027-2032) & (k units) Table 23. Global Cancer Rapid Diagnostic Kit Sales Market Share by Type (2021-2026) Table 24. Global Cancer Rapid Diagnostic Kit Sales Market Share by Type (2027-2032) Table 25. Global Cancer Rapid Diagnostic Kit Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Cancer Rapid Diagnostic Kit Revenue by Type (2021-2026) & (k units) Table 27. Global Cancer Rapid Diagnostic Kit Revenue by Type (2027-2032) & (k units) Table 28. Global Cancer Rapid Diagnostic Kit Revenue Market Share by Type (2021-2026) Table 29. Global Cancer Rapid Diagnostic Kit Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hospital Table 31. Major Manufacturers of Clinic Table 32. Global Cancer Rapid Diagnostic Kit Sales by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global Cancer Rapid Diagnostic Kit Sales by Application (2021-2026) & (k units) Table 34. Global Cancer Rapid Diagnostic Kit Sales by Application (2027-2032) & (k units) Table 35. Global Cancer Rapid Diagnostic Kit Sales Market Share by Application (2021-2026) Table 36. Global Cancer Rapid Diagnostic Kit Sales Market Share by Application (2027-2032) Table 37. Global Cancer Rapid Diagnostic Kit Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 38. Global Cancer Rapid Diagnostic Kit Revenue by Application (2021-2026) & (k units) Table 39. Global Cancer Rapid Diagnostic Kit Revenue by Application (2027-2032) & (k units) Table 40. Global Cancer Rapid Diagnostic Kit Revenue Market Share by Application (2021-2026) Table 41. Global Cancer Rapid Diagnostic Kit Revenue Market Share by Application (2027-2032) Table 42. Global Cancer Rapid Diagnostic Kit Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global Cancer Rapid Diagnostic Kit Sales by Region (2021-2026) & (k units) Table 44. Global Cancer Rapid Diagnostic Kit Sales Market Share by Region (2021-2026) Table 45. Global Cancer Rapid Diagnostic Kit Sales Forecasted by Region (2027-2032) & (k units) Table 46. Global Cancer Rapid Diagnostic Kit Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Cancer Rapid Diagnostic Kit Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 48. North America Cancer Rapid Diagnostic Kit Sales by Country (2021-2026) & (k units) Table 49. North America Cancer Rapid Diagnostic Kit Sales by Country (2027-2032) & (k units) Table 50. Europe Cancer Rapid Diagnostic Kit Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. Europe Cancer Rapid Diagnostic Kit Sales by Country (2021-2026) & (k units) Table 52. Europe Cancer Rapid Diagnostic Kit Sales by Country (2027-2032) & (k units) Table 53. Asia Pacific Cancer Rapid Diagnostic Kit Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Asia Pacific Cancer Rapid Diagnostic Kit Sales by Country (2021-2026) & (k units) Table 55. Asia Pacific Cancer Rapid Diagnostic Kit Sales by Country (2027-2032) & (k units) Table 56. South America, Middle East and Africa Cancer Rapid Diagnostic Kit Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. South America, Middle East and Africa Cancer Rapid Diagnostic Kit Sales by Country (2021-2026) & (k units) Table 58. South America, Middle East and Africa Cancer Rapid Diagnostic Kit Sales by Country (2027-2032) & (k units) Table 59. Global Cancer Rapid Diagnostic Kit Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Cancer Rapid Diagnostic Kit Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Cancer Rapid Diagnostic Kit Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Cancer Rapid Diagnostic Kit Revenue Market Share by Region (2021-2026) Table 63. Global Cancer Rapid Diagnostic Kit Revenue Market Share by Region (2027-2032) Table 64. Yaneng Bioscience (Shenzhen) Co., Ltd. Company Information Table 65. Yaneng Bioscience (Shenzhen) Co., Ltd. Business Overview Table 66. Yaneng Bioscience (Shenzhen) Co., Ltd. Cancer Rapid Diagnostic Kit Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Yaneng Bioscience (Shenzhen) Co., Ltd. Cancer Rapid Diagnostic Kit Product Portfolio Table 68. Yaneng Bioscience (Shenzhen) Co., Ltd. Recent Development Table 69. Xian Tianlong Science and Technology Co.,Ltd Company Information Table 70. Xian Tianlong Science and Technology Co.,Ltd Business Overview Table 71. Xian Tianlong Science and Technology Co.,Ltd Cancer Rapid Diagnostic Kit Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Xian Tianlong Science and Technology Co.,Ltd Cancer Rapid Diagnostic Kit Product Portfolio Table 73. Xian Tianlong Science and Technology Co.,Ltd Recent Development Table 74. XIAMEN SPACEGEN CO.,LTD Company Information Table 75. XIAMEN SPACEGEN CO.,LTD Business Overview Table 76. XIAMEN SPACEGEN CO.,LTD Cancer Rapid Diagnostic Kit Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. XIAMEN SPACEGEN CO.,LTD Cancer Rapid Diagnostic Kit Product Portfolio Table 78. XIAMEN SPACEGEN CO.,LTD Recent Development Table 79. Xiamen Biotime Biotechnology Co., Ltd. Company Information Table 80. Xiamen Biotime Biotechnology Co., Ltd. Business Overview Table 81. Xiamen Biotime Biotechnology Co., Ltd. Cancer Rapid Diagnostic Kit Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Xiamen Biotime Biotechnology Co., Ltd. Cancer Rapid Diagnostic Kit Product Portfolio Table 83. Xiamen Biotime Biotechnology Co., Ltd. Recent Development Table 84. ViennaLab Diagnostics Company Information Table 85. ViennaLab Diagnostics Business Overview Table 86. ViennaLab Diagnostics Cancer Rapid Diagnostic Kit Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. ViennaLab Diagnostics Cancer Rapid Diagnostic Kit Product Portfolio Table 88. ViennaLab Diagnostics Recent Development Table 89. ShenZhen Zijian Biotechnology Co.,Ltd. Company Information Table 90. ShenZhen Zijian Biotechnology Co.,Ltd. Business Overview Table 91. ShenZhen Zijian Biotechnology Co.,Ltd. Cancer Rapid Diagnostic Kit Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. ShenZhen Zijian Biotechnology Co.,Ltd. Cancer Rapid Diagnostic Kit Product Portfolio Table 93. ShenZhen Zijian Biotechnology Co.,Ltd. Recent Development Table 94. Shenzhen Kangshengbao Biotechnology Company Information Table 95. Shenzhen Kangshengbao Biotechnology Business Overview Table 96. Shenzhen Kangshengbao Biotechnology Cancer Rapid Diagnostic Kit Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Shenzhen Kangshengbao Biotechnology Cancer Rapid Diagnostic Kit Product Portfolio Table 98. Shenzhen Kangshengbao Biotechnology Recent Development Table 99. Shanghai Outdo Biotech Co., Ltd. Company Information Table 100. Shanghai Outdo Biotech Co., Ltd. Business Overview Table 101. Shanghai Outdo Biotech Co., Ltd. Cancer Rapid Diagnostic Kit Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Shanghai Outdo Biotech Co., Ltd. Cancer Rapid Diagnostic Kit Product Portfolio Table 103. Shanghai Outdo Biotech Co., Ltd. Recent Development Table 104. Seegene Company Information Table 105. Seegene Business Overview Table 106. Seegene Cancer Rapid Diagnostic Kit Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Seegene Cancer Rapid Diagnostic Kit Product Portfolio Table 108. Seegene Recent Development Table 109. Sansure Biotech Company Information Table 110. Sansure Biotech Business Overview Table 111. Sansure Biotech Cancer Rapid Diagnostic Kit Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Sansure Biotech Cancer Rapid Diagnostic Kit Product Portfolio Table 113. Sansure Biotech Recent Development Table 114. Panagene Inc. Company Information Table 115. Panagene Inc. Business Overview Table 116. Panagene Inc. Cancer Rapid Diagnostic Kit Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Panagene Inc. Cancer Rapid Diagnostic Kit Product Portfolio Table 118. Panagene Inc. Recent Development Table 119. OptiBio Co., Ltd. Company Information Table 120. OptiBio Co., Ltd. Business Overview Table 121. OptiBio Co., Ltd. Cancer Rapid Diagnostic Kit Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. OptiBio Co., Ltd. Cancer Rapid Diagnostic Kit Product Portfolio Table 123. OptiBio Co., Ltd. Recent Development Table 124. LCM Genect Company Information Table 125. LCM Genect Business Overview Table 126. LCM Genect Cancer Rapid Diagnostic Kit Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. LCM Genect Cancer Rapid Diagnostic Kit Product Portfolio Table 128. LCM Genect Recent Development Table 129. Kolplast Group Company Information Table 130. Kolplast Group Business Overview Table 131. Kolplast Group Cancer Rapid Diagnostic Kit Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Kolplast Group Cancer Rapid Diagnostic Kit Product Portfolio Table 133. Kolplast Group Recent Development Table 134. Jiangsu Mole Bioscience CO., LTD. Company Information Table 135. Jiangsu Mole Bioscience CO., LTD. Business Overview Table 136. Jiangsu Mole Bioscience CO., LTD. Cancer Rapid Diagnostic Kit Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Jiangsu Mole Bioscience CO., LTD. Cancer Rapid Diagnostic Kit Product Portfolio Table 138. Jiangsu Mole Bioscience CO., LTD. Recent Development Table 139. Jiangsu MicroDiag Biomedicine Technology Co., Ltd. Company Information Table 140. Jiangsu MicroDiag Biomedicine Technology Co., Ltd. Business Overview Table 141. Jiangsu MicroDiag Biomedicine Technology Co., Ltd. Cancer Rapid Diagnostic Kit Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Jiangsu MicroDiag Biomedicine Technology Co., Ltd. Cancer Rapid Diagnostic Kit Product Portfolio Table 143. Jiangsu MicroDiag Biomedicine Technology Co., Ltd. Recent Development Table 144. Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Company Information Table 145. Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Business Overview Table 146. Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Cancer Rapid Diagnostic Kit Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Cancer Rapid Diagnostic Kit Product Portfolio Table 148. Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Recent Development Table 149. IDL Biotech Company Information Table 150. IDL Biotech Business Overview Table 151. IDL Biotech Cancer Rapid Diagnostic Kit Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 152. IDL Biotech Cancer Rapid Diagnostic Kit Product Portfolio Table 153. IDL Biotech Recent Development Table 154. GenomeMe Labs Inc Company Information Table 155. GenomeMe Labs Inc Business Overview Table 156. GenomeMe Labs Inc Cancer Rapid Diagnostic Kit Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 157. GenomeMe Labs Inc Cancer Rapid Diagnostic Kit Product Portfolio Table 158. GenomeMe Labs Inc Recent Development Table 159. Genetic Biotek Company Information Table 160. Genetic Biotek Business Overview Table 161. Genetic Biotek Cancer Rapid Diagnostic Kit Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 162. Genetic Biotek Cancer Rapid Diagnostic Kit Product Portfolio Table 163. Genetic Biotek Recent Development Table 164. Gencurix Company Information Table 165. Gencurix Business Overview Table 166. Gencurix Cancer Rapid Diagnostic Kit Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 167. Gencurix Cancer Rapid Diagnostic Kit Product Portfolio Table 168. Gencurix Recent Development Table 169. Fujirebio Company Information Table 170. Fujirebio Business Overview Table 171. Fujirebio Cancer Rapid Diagnostic Kit Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 172. Fujirebio Cancer Rapid Diagnostic Kit Product Portfolio Table 173. Fujirebio Recent Development Table 174. Diagenode Company Information Table 175. Diagenode Business Overview Table 176. Diagenode Cancer Rapid Diagnostic Kit Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 177. Diagenode Cancer Rapid Diagnostic Kit Product Portfolio Table 178. Diagenode Recent Development Table 179. Boditech Med Inc. Company Information Table 180. Boditech Med Inc. Business Overview Table 181. Boditech Med Inc. Cancer Rapid Diagnostic Kit Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 182. Boditech Med Inc. Cancer Rapid Diagnostic Kit Product Portfolio Table 183. Boditech Med Inc. Recent Development Table 184. Bioscience (Tianjin) Diagnostic Technology Co.,Ltd Company Information Table 185. Bioscience (Tianjin) Diagnostic Technology Co.,Ltd Business Overview Table 186. Bioscience (Tianjin) Diagnostic Technology Co.,Ltd Cancer Rapid Diagnostic Kit Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 187. Bioscience (Tianjin) Diagnostic Technology Co.,Ltd Cancer Rapid Diagnostic Kit Product Portfolio Table 188. Bioscience (Tianjin) Diagnostic Technology Co.,Ltd Recent Development Table 189. Beijing ACCB Biotech Ltd. Company Information Table 190. Beijing ACCB Biotech Ltd. Business Overview Table 191. Beijing ACCB Biotech Ltd. Cancer Rapid Diagnostic Kit Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 192. Beijing ACCB Biotech Ltd. Cancer Rapid Diagnostic Kit Product Portfolio Table 193. Beijing ACCB Biotech Ltd. Recent Development Table 194. Asuragen Company Information Table 195. Asuragen Business Overview Table 196. Asuragen Cancer Rapid Diagnostic Kit Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 197. Asuragen Cancer Rapid Diagnostic Kit Product Portfolio Table 198. Asuragen Recent Development Table 199. Key Raw Materials Table 200. Raw Materials Key Suppliers Table 201. Cancer Rapid Diagnostic Kit Distributors List Table 202. Cancer Rapid Diagnostic Kit Customers List Table 203. Research Programs/Design for This Report Table 204. Authors List of This Report Table 205. Secondary Sources Table 206. Primary Sources List of Figures Figure 1. Cancer Rapid Diagnostic Kit Product Image Figure 2. Global Cancer Rapid Diagnostic Kit Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cancer Rapid Diagnostic Kit Market Size (2021-2032) & (US$ Million) Figure 4. Global Cancer Rapid Diagnostic Kit Sales (2021-2032) & (k units) Figure 5. Global Cancer Rapid Diagnostic Kit Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Cancer Rapid Diagnostic Kit Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Test For Tumor Markers Image Figure 9. Test Gene Image Figure 10. Test Protein Image Figure 11. Others Image Figure 12. Global Cancer Rapid Diagnostic Kit Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Cancer Rapid Diagnostic Kit Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Cancer Rapid Diagnostic Kit Sales Market Share by Type (2021-2032) Figure 15. Global Cancer Rapid Diagnostic Kit Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Cancer Rapid Diagnostic Kit Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Cancer Rapid Diagnostic Kit Revenue Market Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Clinic Image Figure 20. Global Cancer Rapid Diagnostic Kit Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global Cancer Rapid Diagnostic Kit Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Cancer Rapid Diagnostic Kit Sales Market Share by Application (2021-2032) Figure 23. Global Cancer Rapid Diagnostic Kit Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Cancer Rapid Diagnostic Kit Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Cancer Rapid Diagnostic Kit Revenue Market Share by Application (2021-2032) Figure 26. North America Cancer Rapid Diagnostic Kit Sales and Growth Rate (2021-2032) & (k units) Figure 27. North America Cancer Rapid Diagnostic Kit Sales Market Share by Country (2021-2032) Figure 28. U.S. Cancer Rapid Diagnostic Kit Sales and Growth Rate (2021-2032) & (k units) Figure 29. Canada Cancer Rapid Diagnostic Kit Sales and Growth Rate (2021-2032) & (k units) Figure 30. Mexico Cancer Rapid Diagnostic Kit Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Cancer Rapid Diagnostic Kit Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Cancer Rapid Diagnostic Kit Sales Market Share by Country (2021-2032) Figure 33. Germany Cancer Rapid Diagnostic Kit Sales and Growth Rate (2021-2032) & (k units) Figure 34. France Cancer Rapid Diagnostic Kit Sales and Growth Rate (2021-2032) & (k units) Figure 35. U.K. Cancer Rapid Diagnostic Kit Sales and Growth Rate (2021-2032) & (k units) Figure 36. Italy Cancer Rapid Diagnostic Kit Sales and Growth Rate (2021-2032) & (k units) Figure 37. Netherlands Cancer Rapid Diagnostic Kit Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Cancer Rapid Diagnostic Kit Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Cancer Rapid Diagnostic Kit Sales Market Share by Country (2021-2032) Figure 40. China Cancer Rapid Diagnostic Kit Sales and Growth Rate (2021-2032) & (k units) Figure 41. Japan Cancer Rapid Diagnostic Kit Sales and Growth Rate (2021-2032) & (k units) Figure 42. South Korea Cancer Rapid Diagnostic Kit Sales and Growth Rate (2021-2032) & (k units) Figure 43. Southeast Asia Cancer Rapid Diagnostic Kit Sales and Growth Rate (2021-2032) & (k units) Figure 44. India Cancer Rapid Diagnostic Kit Sales and Growth Rate (2021-2032) & (k units) Figure 45. Australia Cancer Rapid Diagnostic Kit Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Cancer Rapid Diagnostic Kit Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Cancer Rapid Diagnostic Kit Sales Market Share by Country (2021-2032) Figure 48. Brazil Cancer Rapid Diagnostic Kit Sales and Growth Rate (2021-2032) & (k units) Figure 49. South Africa Cancer Rapid Diagnostic Kit Sales and Growth Rate (2021-2032) & (k units) Figure 50. Saudi Arabia Cancer Rapid Diagnostic Kit Sales and Growth Rate (2021-2032) & (k units) Figure 51. Turkey Cancer Rapid Diagnostic Kit Sales and Growth Rate (2021-2032) & (k units) Figure 52. Argentina Cancer Rapid Diagnostic Kit Sales and Growth Rate (2021-2032) & (k units) Figure 53. UAE Cancer Rapid Diagnostic Kit Sales and Growth Rate (2021-2032) & (k units) Figure 54. Egypt Cancer Rapid Diagnostic Kit Sales and Growth Rate (2021-2032) & (k units) Figure 55. Chile Cancer Rapid Diagnostic Kit Sales and Growth Rate (2021-2032) & (k units) Figure 56. Global Cancer Rapid Diagnostic Kit Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Cancer Rapid Diagnostic Kit Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Cancer Rapid Diagnostic Kit Revenue (2021-2032) & (US$ Million) Figure 59. North America Cancer Rapid Diagnostic Kit Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Cancer Rapid Diagnostic Kit Revenue (2021-2032) & (US$ Million) Figure 61. Europe Cancer Rapid Diagnostic Kit Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Cancer Rapid Diagnostic Kit Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Cancer Rapid Diagnostic Kit Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Cancer Rapid Diagnostic Kit Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Cancer Rapid Diagnostic Kit Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Cancer Rapid Diagnostic Kit Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Cancer Rapid Diagnostic Kit Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Test For Tumor Markers
  • Test Gene
  • Test Protein
  • Others
Applications
  • Hospital
  • Clinic
Companies covered
  • Yaneng Bioscience (Shenzhen) Co., Ltd.
  • Xian Tianlong Science and Technology Co.,Ltd
  • XIAMEN SPACEGEN CO.,LTD
  • Xiamen Biotime Biotechnology Co., Ltd.
  • ViennaLab Diagnostics
  • ShenZhen Zijian Biotechnology Co.,Ltd.
  • Shenzhen Kangshengbao Biotechnology
  • Shanghai Outdo Biotech Co., Ltd.
  • Seegene
  • Sansure Biotech
  • Panagene Inc.
  • OptiBio Co., Ltd.
  • LCM Genect
  • Kolplast Group
  • Jiangsu Mole Bioscience CO., LTD.
  • Jiangsu MicroDiag Biomedicine Technology Co., Ltd.
  • Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.
  • IDL Biotech
  • GenomeMe Labs Inc
  • Genetic Biotek
  • Gencurix
  • Fujirebio
  • Diagenode
  • Boditech Med Inc.
  • Bioscience (Tianjin) Diagnostic Technology Co.,Ltd
  • Beijing ACCB Biotech Ltd.
  • Asuragen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cancer Rapid Diagnostic Kit Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cancer Rapid Diagnostic Kit Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Cancer Rapid Diagnostic Kit Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Cancer Rapid Diagnostic Kit Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Cancer Rapid Diagnostic Kit Market Dynamics
  1. 2.1 Cancer Rapid Diagnostic Kit Industry Trends
  2. 2.2 Cancer Rapid Diagnostic Kit Industry Drivers
  3. 2.3 Cancer Rapid Diagnostic Kit Industry Opportunities and Challenges
  4. 2.4 Cancer Rapid Diagnostic Kit Industry Restraints
3 Cancer Rapid Diagnostic Kit Market by Manufacturers
  1. 3.1 Global Cancer Rapid Diagnostic Kit Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Cancer Rapid Diagnostic Kit Sales by Manufacturers (2021-2026)
  3. 3.3 Global Cancer Rapid Diagnostic Kit Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Cancer Rapid Diagnostic Kit Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cancer Rapid Diagnostic Kit Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Cancer Rapid Diagnostic Kit Manufacturers, Product Type & Application
  7. 3.7 Global Cancer Rapid Diagnostic Kit Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cancer Rapid Diagnostic Kit Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cancer Rapid Diagnostic Kit Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cancer Rapid Diagnostic Kit Tier 1, Tier 2, and Tier 3
4 Cancer Rapid Diagnostic Kit Market by Type
  1. 4.1 Cancer Rapid Diagnostic Kit Type Introduction
  2. 4.1.1 Test For Tumor Markers
  3. 4.1.2 Test Gene
  4. 4.1.3 Test Protein
  5. 4.1.4 Others
  6. 4.2 Global Cancer Rapid Diagnostic Kit Sales by Type
  7. 4.2.1 Global Cancer Rapid Diagnostic Kit Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Cancer Rapid Diagnostic Kit Sales by Type (2021-2032)
  9. 4.2.3 Global Cancer Rapid Diagnostic Kit Sales Market Share by Type (2021-2032)
  10. 4.3 Global Cancer Rapid Diagnostic Kit Revenue by Type
  11. 4.3.1 Global Cancer Rapid Diagnostic Kit Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Cancer Rapid Diagnostic Kit Revenue by Type (2021-2032)
  13. 4.3.3 Global Cancer Rapid Diagnostic Kit Revenue Market Share by Type (2021-2032)
5 Cancer Rapid Diagnostic Kit Market by Application
  1. 5.1 Cancer Rapid Diagnostic Kit Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Cancer Rapid Diagnostic Kit Sales by Application
  5. 5.2.1 Global Cancer Rapid Diagnostic Kit Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Cancer Rapid Diagnostic Kit Sales by Application (2021-2032)
  7. 5.2.3 Global Cancer Rapid Diagnostic Kit Sales Market Share by Application (2021-2032)
  8. 5.3 Global Cancer Rapid Diagnostic Kit Revenue by Application
  9. 5.3.1 Global Cancer Rapid Diagnostic Kit Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Cancer Rapid Diagnostic Kit Revenue by Application (2021-2032)
  11. 5.3.3 Global Cancer Rapid Diagnostic Kit Revenue Market Share by Application (2021-2032)
6 Global Cancer Rapid Diagnostic Kit Sales by Region
  1. 6.1 Global Cancer Rapid Diagnostic Kit Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cancer Rapid Diagnostic Kit Sales by Region (2021-2032)
  3. 6.2.1 Global Cancer Rapid Diagnostic Kit Sales by Region (2021-2026)
  4. 6.2.2 Global Cancer Rapid Diagnostic Kit Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cancer Rapid Diagnostic Kit Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Cancer Rapid Diagnostic Kit Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Cancer Rapid Diagnostic Kit Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Cancer Rapid Diagnostic Kit Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Cancer Rapid Diagnostic Kit Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Cancer Rapid Diagnostic Kit Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Cancer Rapid Diagnostic Kit Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Cancer Rapid Diagnostic Kit Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Cancer Rapid Diagnostic Kit Revenue by Region
  1. 7.1 Global Cancer Rapid Diagnostic Kit Revenue by Region
  2. 7.1.1 Global Cancer Rapid Diagnostic Kit Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Cancer Rapid Diagnostic Kit Revenue by Region (2021-2026)
  4. 7.1.3 Global Cancer Rapid Diagnostic Kit Revenue by Region (2027-2032)
  5. 7.1.4 Global Cancer Rapid Diagnostic Kit Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Cancer Rapid Diagnostic Kit Revenue (2021-2032)
  8. 7.2.2 North America Cancer Rapid Diagnostic Kit Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Cancer Rapid Diagnostic Kit Revenue (2021-2032)
  11. 7.3.2 Europe Cancer Rapid Diagnostic Kit Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Cancer Rapid Diagnostic Kit Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Cancer Rapid Diagnostic Kit Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Cancer Rapid Diagnostic Kit Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Cancer Rapid Diagnostic Kit Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Yaneng Bioscience (Shenzhen) Co., Ltd.
  2. 8.1.1 Yaneng Bioscience (Shenzhen) Co., Ltd. Company Information
  3. 8.1.2 Yaneng Bioscience (Shenzhen) Co., Ltd. Business Overview
  4. 8.1.3 Yaneng Bioscience (Shenzhen) Co., Ltd. Cancer Rapid Diagnostic Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Yaneng Bioscience (Shenzhen) Co., Ltd. Cancer Rapid Diagnostic Kit Product Portfolio
  6. 8.1.5 Yaneng Bioscience (Shenzhen) Co., Ltd. Recent Developments
  7. 8.2 Xian Tianlong Science and Technology Co.,Ltd
  8. 8.2.1 Xian Tianlong Science and Technology Co.,Ltd Company Information
  9. 8.2.2 Xian Tianlong Science and Technology Co.,Ltd Business Overview
  10. 8.2.3 Xian Tianlong Science and Technology Co.,Ltd Cancer Rapid Diagnostic Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Xian Tianlong Science and Technology Co.,Ltd Cancer Rapid Diagnostic Kit Product Portfolio
  12. 8.2.5 Xian Tianlong Science and Technology Co.,Ltd Recent Developments
  13. 8.3 XIAMEN SPACEGEN CO.,LTD
  14. 8.3.1 XIAMEN SPACEGEN CO.,LTD Company Information
  15. 8.3.2 XIAMEN SPACEGEN CO.,LTD Business Overview
  16. 8.3.3 XIAMEN SPACEGEN CO.,LTD Cancer Rapid Diagnostic Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 XIAMEN SPACEGEN CO.,LTD Cancer Rapid Diagnostic Kit Product Portfolio
  18. 8.3.5 XIAMEN SPACEGEN CO.,LTD Recent Developments
  19. 8.4 Xiamen Biotime Biotechnology Co., Ltd.
  20. 8.4.1 Xiamen Biotime Biotechnology Co., Ltd. Company Information
  21. 8.4.2 Xiamen Biotime Biotechnology Co., Ltd. Business Overview
  22. 8.4.3 Xiamen Biotime Biotechnology Co., Ltd. Cancer Rapid Diagnostic Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Xiamen Biotime Biotechnology Co., Ltd. Cancer Rapid Diagnostic Kit Product Portfolio
  24. 8.4.5 Xiamen Biotime Biotechnology Co., Ltd. Recent Developments
  25. 8.5 ViennaLab Diagnostics
  26. 8.5.1 ViennaLab Diagnostics Company Information
  27. 8.5.2 ViennaLab Diagnostics Business Overview
  28. 8.5.3 ViennaLab Diagnostics Cancer Rapid Diagnostic Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 ViennaLab Diagnostics Cancer Rapid Diagnostic Kit Product Portfolio
  30. 8.5.5 ViennaLab Diagnostics Recent Developments
  31. 8.6 ShenZhen Zijian Biotechnology Co.,Ltd.
  32. 8.6.1 ShenZhen Zijian Biotechnology Co.,Ltd. Company Information
  33. 8.6.2 ShenZhen Zijian Biotechnology Co.,Ltd. Business Overview
  34. 8.6.3 ShenZhen Zijian Biotechnology Co.,Ltd. Cancer Rapid Diagnostic Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 ShenZhen Zijian Biotechnology Co.,Ltd. Cancer Rapid Diagnostic Kit Product Portfolio
  36. 8.6.5 ShenZhen Zijian Biotechnology Co.,Ltd. Recent Developments
  37. 8.7 Shenzhen Kangshengbao Biotechnology
  38. 8.7.1 Shenzhen Kangshengbao Biotechnology Company Information
  39. 8.7.2 Shenzhen Kangshengbao Biotechnology Business Overview
  40. 8.7.3 Shenzhen Kangshengbao Biotechnology Cancer Rapid Diagnostic Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Shenzhen Kangshengbao Biotechnology Cancer Rapid Diagnostic Kit Product Portfolio
  42. 8.7.5 Shenzhen Kangshengbao Biotechnology Recent Developments
  43. 8.8 Shanghai Outdo Biotech Co., Ltd.
  44. 8.8.1 Shanghai Outdo Biotech Co., Ltd. Company Information
  45. 8.8.2 Shanghai Outdo Biotech Co., Ltd. Business Overview
  46. 8.8.3 Shanghai Outdo Biotech Co., Ltd. Cancer Rapid Diagnostic Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Shanghai Outdo Biotech Co., Ltd. Cancer Rapid Diagnostic Kit Product Portfolio
  48. 8.8.5 Shanghai Outdo Biotech Co., Ltd. Recent Developments
  49. 8.9 Seegene
  50. 8.9.1 Seegene Company Information
  51. 8.9.2 Seegene Business Overview
  52. 8.9.3 Seegene Cancer Rapid Diagnostic Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Seegene Cancer Rapid Diagnostic Kit Product Portfolio
  54. 8.9.5 Seegene Recent Developments
  55. 8.10 Sansure Biotech
  56. 8.10.1 Sansure Biotech Company Information
  57. 8.10.2 Sansure Biotech Business Overview
  58. 8.10.3 Sansure Biotech Cancer Rapid Diagnostic Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Sansure Biotech Cancer Rapid Diagnostic Kit Product Portfolio
  60. 8.10.5 Sansure Biotech Recent Developments
  61. 8.11 Panagene Inc.
  62. 8.11.1 Panagene Inc. Company Information
  63. 8.11.2 Panagene Inc. Business Overview
  64. 8.11.3 Panagene Inc. Cancer Rapid Diagnostic Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Panagene Inc. Cancer Rapid Diagnostic Kit Product Portfolio
  66. 8.11.5 Panagene Inc. Recent Developments
  67. 8.12 OptiBio Co., Ltd.
  68. 8.12.1 OptiBio Co., Ltd. Company Information
  69. 8.12.2 OptiBio Co., Ltd. Business Overview
  70. 8.12.3 OptiBio Co., Ltd. Cancer Rapid Diagnostic Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 OptiBio Co., Ltd. Cancer Rapid Diagnostic Kit Product Portfolio
  72. 8.12.5 OptiBio Co., Ltd. Recent Developments
  73. 8.13 LCM Genect
  74. 8.13.1 LCM Genect Company Information
  75. 8.13.2 LCM Genect Business Overview
  76. 8.13.3 LCM Genect Cancer Rapid Diagnostic Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 LCM Genect Cancer Rapid Diagnostic Kit Product Portfolio
  78. 8.13.5 LCM Genect Recent Developments
  79. 8.14 Kolplast Group
  80. 8.14.1 Kolplast Group Company Information
  81. 8.14.2 Kolplast Group Business Overview
  82. 8.14.3 Kolplast Group Cancer Rapid Diagnostic Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Kolplast Group Cancer Rapid Diagnostic Kit Product Portfolio
  84. 8.14.5 Kolplast Group Recent Developments
  85. 8.15 Jiangsu Mole Bioscience CO., LTD.
  86. 8.15.1 Jiangsu Mole Bioscience CO., LTD. Company Information
  87. 8.15.2 Jiangsu Mole Bioscience CO., LTD. Business Overview
  88. 8.15.3 Jiangsu Mole Bioscience CO., LTD. Cancer Rapid Diagnostic Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Jiangsu Mole Bioscience CO., LTD. Cancer Rapid Diagnostic Kit Product Portfolio
  90. 8.15.5 Jiangsu Mole Bioscience CO., LTD. Recent Developments
  91. 8.16 Jiangsu MicroDiag Biomedicine Technology Co., Ltd.
  92. 8.16.1 Jiangsu MicroDiag Biomedicine Technology Co., Ltd. Company Information
  93. 8.16.2 Jiangsu MicroDiag Biomedicine Technology Co., Ltd. Business Overview
  94. 8.16.3 Jiangsu MicroDiag Biomedicine Technology Co., Ltd. Cancer Rapid Diagnostic Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Jiangsu MicroDiag Biomedicine Technology Co., Ltd. Cancer Rapid Diagnostic Kit Product Portfolio
  96. 8.16.5 Jiangsu MicroDiag Biomedicine Technology Co., Ltd. Recent Developments
  97. 8.17 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd.
  98. 8.17.1 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Company Information
  99. 8.17.2 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Business Overview
  100. 8.17.3 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Cancer Rapid Diagnostic Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Cancer Rapid Diagnostic Kit Product Portfolio
  102. 8.17.5 Jiangsu Macro & Micro-Test Med-Tech Co., Ltd. Recent Developments
  103. 8.18 IDL Biotech
  104. 8.18.1 IDL Biotech Company Information
  105. 8.18.2 IDL Biotech Business Overview
  106. 8.18.3 IDL Biotech Cancer Rapid Diagnostic Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 IDL Biotech Cancer Rapid Diagnostic Kit Product Portfolio
  108. 8.18.5 IDL Biotech Recent Developments
  109. 8.19 GenomeMe Labs Inc
  110. 8.19.1 GenomeMe Labs Inc Company Information
  111. 8.19.2 GenomeMe Labs Inc Business Overview
  112. 8.19.3 GenomeMe Labs Inc Cancer Rapid Diagnostic Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 GenomeMe Labs Inc Cancer Rapid Diagnostic Kit Product Portfolio
  114. 8.19.5 GenomeMe Labs Inc Recent Developments
  115. 8.20 Genetic Biotek
  116. 8.20.1 Genetic Biotek Company Information
  117. 8.20.2 Genetic Biotek Business Overview
  118. 8.20.3 Genetic Biotek Cancer Rapid Diagnostic Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Genetic Biotek Cancer Rapid Diagnostic Kit Product Portfolio
  120. 8.20.5 Genetic Biotek Recent Developments
  121. 8.21 Gencurix
  122. 8.21.1 Gencurix Company Information
  123. 8.21.2 Gencurix Business Overview
  124. 8.21.3 Gencurix Cancer Rapid Diagnostic Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Gencurix Cancer Rapid Diagnostic Kit Product Portfolio
  126. 8.21.5 Gencurix Recent Developments
  127. 8.22 Fujirebio
  128. 8.22.1 Fujirebio Company Information
  129. 8.22.2 Fujirebio Business Overview
  130. 8.22.3 Fujirebio Cancer Rapid Diagnostic Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Fujirebio Cancer Rapid Diagnostic Kit Product Portfolio
  132. 8.22.5 Fujirebio Recent Developments
  133. 8.23 Diagenode
  134. 8.23.1 Diagenode Company Information
  135. 8.23.2 Diagenode Business Overview
  136. 8.23.3 Diagenode Cancer Rapid Diagnostic Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Diagenode Cancer Rapid Diagnostic Kit Product Portfolio
  138. 8.23.5 Diagenode Recent Developments
  139. 8.24 Boditech Med Inc.
  140. 8.24.1 Boditech Med Inc. Company Information
  141. 8.24.2 Boditech Med Inc. Business Overview
  142. 8.24.3 Boditech Med Inc. Cancer Rapid Diagnostic Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Boditech Med Inc. Cancer Rapid Diagnostic Kit Product Portfolio
  144. 8.24.5 Boditech Med Inc. Recent Developments
  145. 8.25 Bioscience (Tianjin) Diagnostic Technology Co.,Ltd
  146. 8.25.1 Bioscience (Tianjin) Diagnostic Technology Co.,Ltd Company Information
  147. 8.25.2 Bioscience (Tianjin) Diagnostic Technology Co.,Ltd Business Overview
  148. 8.25.3 Bioscience (Tianjin) Diagnostic Technology Co.,Ltd Cancer Rapid Diagnostic Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Bioscience (Tianjin) Diagnostic Technology Co.,Ltd Cancer Rapid Diagnostic Kit Product Portfolio
  150. 8.25.5 Bioscience (Tianjin) Diagnostic Technology Co.,Ltd Recent Developments
  151. 8.26 Beijing ACCB Biotech Ltd.
  152. 8.26.1 Beijing ACCB Biotech Ltd. Company Information
  153. 8.26.2 Beijing ACCB Biotech Ltd. Business Overview
  154. 8.26.3 Beijing ACCB Biotech Ltd. Cancer Rapid Diagnostic Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  155. 8.26.4 Beijing ACCB Biotech Ltd. Cancer Rapid Diagnostic Kit Product Portfolio
  156. 8.26.5 Beijing ACCB Biotech Ltd. Recent Developments
  157. 8.27 Asuragen
  158. 8.27.1 Asuragen Company Information
  159. 8.27.2 Asuragen Business Overview
  160. 8.27.3 Asuragen Cancer Rapid Diagnostic Kit Sales, Price, Revenue and Gross Margin (2021-2026)
  161. 8.27.4 Asuragen Cancer Rapid Diagnostic Kit Product Portfolio
  162. 8.27.5 Asuragen Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cancer Rapid Diagnostic Kit Value Chain Analysis
  2. 9.1.1 Cancer Rapid Diagnostic Kit Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cancer Rapid Diagnostic Kit Production Mode & Process
  6. 9.2 Cancer Rapid Diagnostic Kit Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cancer Rapid Diagnostic Kit Distributors
  9. 9.2.3 Cancer Rapid Diagnostic Kit Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst